Hypera’s Surprise R$1.5 Billion Capital Raise Divides Wall Street and Fuels Pharma M&A Speculation

2026-02-05 - 12:35

Key Points Hypera, maker of Buscopan and Benegrip, announced an unexpected R$1.5 billion (~$290 million) equity raise at a 17% discount, sending shares down 10.3% and wiping R$1.6 billion (~$310 million) from its market value The move comes weeks before binding bids are due for Sanofi’s Medley generics unit — a US$500 million-plus deal that